Voleak Choeurng

3.6k citations

41 papers · 1.4k indexed · h-index 17

Pulmonary and Respiratory Medicine top 2%
- Prostate Cancer Treatment and Research 24
- Prostate Cancer Diagnosis and Treatment 22
Cancer Research top 5%
- Cancer, Lipids, and Metabolism 4
- Cancer Genomics and Diagnostics 4
Health, Toxicology and Mutagenesis top 5%
Oncology top 10%
- CAR-T cell therapy research 3
Statistics and Probability top 5%
Hematology
- Multiple Myeloma Research and Treatments 6
Molecular Biology
- Molecular Biology Techniques and Applications 5
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 5

Co-authors: Elai Davicioni Kasra Yousefi Eric A. Klein Christine Buerki Robert B. Den Zaid Haddad Ashley E. Ross Adam P. Dicker
Cited by: Pulmonary and Respiratory Medicine Cancer Research Health, Toxicology and Mutagenesis
Journals: Journal of Clinical Oncology (10 papers)SHILAP Revista de lepidopterología (1 paper)Blood (4 papers)
Partner nations: United States Canada Australia

In The Last Decade

Voleak Choeurng

39 papers receiving 1.3k citations

Peers

Countries citing papers authored by Voleak Choeurng

Since Specialization

Citations

This map shows the geographic impact of Voleak Choeurng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Voleak Choeurng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Voleak Choeurng more than expected).

Fields of papers citing papers by Voleak Choeurng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Voleak Choeurng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Voleak Choeurng. The network helps show where Voleak Choeurng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Voleak Choeurng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Voleak Choeurng Line = papers co-authored together Voleak Choeurng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cevostamab in Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study Demonstrate Clinically Meaningful Activity and Manageable Safety and Inform the Doses and Regimen for Combination Studies Blood ·Joshua Richter,Sheeba K. Thomas,Amrita Krishnan,Jacob P. Laubach,Adam D. Cohen,Suzanne Trudel,Luciano J. Costa,Nizar J. Bahlis,Peter A. Forsberg,Rayan Kaedbey,Rafaël Fonseca,Andrew Spencer,Paula Rodríguez‐Otero,María‐Victoria Mateos,Chihunt Wong,James Cooper,Tulika Tyagi,Rin Nakamura,Voleak Choeurng,Alexander M. Lesokhin	2024	8
2	Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma SHILAP Revista de lepidopterología ·Torben Plesner,Simon J. Harrison,Hang Quach,Cindy Lee,Adam Bryant,Annette Juul Vangsted,Jane Estell,Michel Delforge,Fritz Offner,Patrick J. Twomey,Voleak Choeurng,Junyi Li,Robert L. Hendricks,Shannon M. Ruppert,Teiko Sumiyoshi,Karen K. Miller,Eunpi Cho,Fredrik Schjesvold	2023	16
3	P946: TOCILIZUMAB PRE-TREATMENT SIGNIFICANTLY REDUCES THE INCIDENCE OF CYTOKINE RELEASE SYNDROME IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE CEVOSTAMAB HemaSphere ·María‐Victoria Mateos,Nizar J. Bahlis,Andrew Spencer,Rayan Kaedbey,Paula Rodríguez‐Otero,Simon J. Harrison,Chihunt Wong,Grant K. Goodman,Rin Nakamura,Voleak Choeurng,James Fenimore Cooper,Suzanne Trudel	2023	4
4	An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer Gynecologic Oncology ·Joyce F. Liu,Howard A. Burris,Judy S. Wang,Lisa Barroilhet,Martin Gutierrez,Yulei Wang,Anjali Vaze,Renee Commerford,Stephanie Royer‐Joo,Voleak Choeurng,Eric W. Humke,Kathleen N. Moore	2021	37
5	Initial Clinical Activity and Safety of BFCR4350A, a FcRH5/CD3 T-Cell-Engaging Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma Blood ·Adam D. Cohen,Simon J. Harrison,Amrita Krishnan,Rafaël Fonseca,Peter A. Forsberg,Andrew Spencer,Jesús G. Berdeja,Jacob P. Laubach,Mengsong Li,Voleak Choeurng,Anjali Vaze,Divya Samineni,Teiko Sumiyoshi,James Cooper,Bernard M. Fine,Suzanne Trudel	2020	65
6	Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer European Urology ·Brandon A. Mahal,David D. Yang,Natalie Q. Wang,Mohammed Alshalalfa,Elai Davicioni,Voleak Choeurng,Edward M. Schaeffer,Ashley E. Ross,Daniel E. Spratt,Robert B. Den,Neil E. Martin,Kent W. Mouw,Peter F. Orio,Toni K. Choueiri,Mary-Ellen Taplin,Quoc‐Dien Trinh,Felix Y. Feng,Paul L. Nguyen	2018	72
7	Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer Prostate Cancer and Prostatic Diseases ·Paul L. Nguyen,Neil E. Martin,Voleak Choeurng,Beatrix Palmer-Aronsten,Tyler Kolisnik,Clair J. Beard,Peter F. Orio,Michelle D. Nezolosky,Yu‐Wei Chen,H Shin,Elai Davicioni,Felix Y. Feng	2017	35
8	Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features European Urology ·R. Jeffrey Karnes,Voleak Choeurng,Ashley E. Ross,Edward M. Schaeffer,Eric A. Klein,Stephen J. Freedland,Nicholas Erho,Kasra Yousefi,Mandeep Takhar,Elai Davicioni,Matthew R. Cooperberg,Bruce J. Trock	2017	42
9	Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy European Urology ·Stephen J. Freedland,Voleak Choeurng,Lauren E. Howard,Amanda M. De Hoedt,Marguerite du Plessis,Kasra Yousefi,Lucia L.C. Lam,Christine Buerki,Seong Ra,Bruce A. Robbins,Edouard J. Trabulsi,Nikhil Shah,Firas Abdollah,Felix Y. Feng,Elai Davicioni,Adam P. Dicker,R. Jeffrey Karnes,Robert B. Den	2016	51
10	Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk Urology ·Eric A. Klein,Zaid Haddad,Kasra Yousefi,Lucia L.C. Lam,Qiqi Wang,Voleak Choeurng,Beatrix Palmer-Aronsten,Christine Buerki,Elai Davicioni,Jianbo Li,Michael W. Kattan,Andrew J. Stephenson,Cristina Magi‐Galluzzi	2016	121
11	Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk Prostate Cancer and Prostatic Diseases ·Ashley E. Ross,Robert B. Den,Kasra Yousefi,Bruce J. Trock,Jeffrey J. Tosoian,Elai Davicioni,Darby J. S. Thompson,Voleak Choeurng,Zaid Haddad,Phuoc T. Tran,Edouard J. Trabulsi,Leonard G. Gomella,Costas D. Lallas,Firas Abdollah,Felix Y. Feng,Eric A. Klein,Adam P. Dicker,Stephen J. Freedland,R. Jeffrey Karnes,Edward M. Schaeffer	2016	18
12	Development and validation of genomic signature to predict ADT treatment failure. Journal of Clinical Oncology ·Jeffrey Karnes,Hussam Al-Deen Ashab,Bruce J. Trock,Ashley E. Ross,Harrison Tsai,Jeffrey J. Tosoian,Mohammed Alshalalfa,Voleak Choeurng,Kasra Yousefi,Zaid Haddad,Firas Abdollah,Eric A. Klein,Paul L. Nguyen,Felix Y. Feng,Adam P. Dicker,Robert B. Den,Elai Davicioni,Tamara L. Lotan,Edward M. Schaeffer	2016	1
13	730 Decipher genomic classifier measured on prostate biopsy predicts 10 year metastasis risk European Urology Supplements ·Eric A. Klein,Zaid Haddad,Kasra Yousefi,Lucia L.C. Lam,Q. Wang,Voleak Choeurng,Beatrix Palmer-Aronsten,Christine Buerki,Elai Davicioni,J. Li,Michael W. Kattan,Andrew J. Stephenson,C. Magi-Galluzzi	2016	0
14	Efficacy of early and delayed radiation in a prostatectomy cohort adjusted for genomic and clinical risk. Journal of Clinical Oncology ·Robert B. Den,Kasra Yousefi,Bruce J. Trock,Elai Davicioni,Jeffrey J. Tosoian,Darby J. S. Thompson,Voleak Choeurng,Zaid Haddad,Phuoc T. Tran,Edouard J. Trabulsi,Leonard G. Gomella,Costas D. Lallas,Firas Abdollah,Felix Y. Feng,Adam P. Dicker,Stephen J. Freedland,Jeffrey Karnes,Edward M. Schaeffer,Ashley E. Ross	2016	1
15	Validation of a Genomic Classifier for Prediction of Metastasis Following Postoperative Salvage Radiation Therapy International Journal of Radiation OncologyBiologyPhysics ·Robert B. Den,Voleak Choeurng,Lauren E. Howard,Amanda M. De Hoedt,Marguerite du Plessis,Kasra Yousefi,Lucia L.C. Lam,Christine Buerki,Edouard J. Trabulsi,Adam P. Dicker,Elai Davicioni,Jeffrey Karnes,Stephen J. Freedland	2015	0
16	Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location European Urology ·Farzana A. Faisal,Debasish Sundi,Jeffrey J. Tosoian,Voleak Choeurng,Mohammed Alshalalfa,Ashley E. Ross,Eric A. Klein,Robert B. Den,Adam P. Dicker,Nicholas Erho,Elai Davicioni,Tamara L. Lotan,Edward M. Schaeffer	2015	69
17	Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men European Urology ·Ashley E. Ross,Michael H. Johnson,Kasra Yousefi,Elai Davicioni,George J. Netto,Luigi Marchionni,Helen Fedor,Stephanie Glavaris,Voleak Choeurng,Christine Buerki,Nicholas Erho,Lucia L.C. Lam,Elizabeth B. Humphreys,Sheila F. Faraj,Stephania Martins Bezerra,Misop Han,Alan W. Partin,Bruce J. Trock,Edward M. Schaeffer	2015	157
18	Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting The Journal of Urology ·Andrew G. Glass,Michael C. Leo,Zaid Haddad,Kasra Yousefi,Marguerite du Plessis,Chuhe Chen,Voleak Choeurng,Firas Abdollah,Bruce A. Robbins,Seong Ra,Kathryn Richert-Boe,Christine Buerki,Kathy H. Pearson,Elai Davicioni,Sheila Weinmann	2015	27
19	Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer Journal of Clinical Oncology ·Kosj Yamoah,Michael H. Johnson,Voleak Choeurng,Farzana A. Faisal,Kasra Yousefi,Zaid Haddad,Ashley E. Ross,Mohammed Alshalafa,Robert B. Den,Priti Lal,Michael Feldman,Adam P. Dicker,Eric A. Klein,Elai Davicioni,Timothy R. Rebbeck,Edward M. Schaeffer	2015	101
20	A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy European Urology ·Eric A. Klein,Kasra Yousefi,Zaid Haddad,Voleak Choeurng,Christine Buerki,Andrew J. Stephenson,Jianbo Li,Michael W. Kattan,Cristina Magi‐Galluzzi,Elai Davicioni	2014	123

About Voleak Choeurng

Voleak Choeurng is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Hematology, having authored 41 papers that have together received 1.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (24 papers), Prostate Cancer Diagnosis and Treatment (22 papers), Multiple Myeloma Research and Treatments (6 papers), Molecular Biology Techniques and Applications (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer, Lipids, and Metabolism (4 papers), Cancer Genomics and Diagnostics (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (939 citations), Cancer Research (392 citations) and Health, Toxicology and Mutagenesis (157 citations). Voleak Choeurng has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Elai Davicioni, Kasra Yousefi, Eric A. Klein, Christine Buerki, Robert B. Den, Zaid Haddad, Ashley E. Ross, Adam P. Dicker, Edward M. Schaeffer and Felix Y. Feng. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact